Eli Lilly Boosts Q1 2026 Earnings, Expands into Vaccines with $3.8 B Acquisition
Eli Lilly and Company (NYSE: LLY) announced its first‑quarter 2026 results on April 30, 2026. Worldwide revenue rose 5...
Read story →Tag: Acquisitions
View all →
Pfizer Faces Revenue Decline and Patent Cliffs, but New Deals and Acquisitions Offer a Path Forward
Pfizer Inc. reported a 1.6% drop in 2025 revenue to $62.6 billion, a sharp decline from the $100 billion peak reached in...
Read story →
Corporate Governance, M&A Activity, and Private Equity Drive 2025-26 Business Landscape
When the world’s biggest deals collide with the quiet reshuffling of private‑equity stakes, the business landscape o...
Read story →